NK Cell Lectin-Like Receptor Subfamily B
"NK Cell Lectin-Like Receptor Subfamily B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of NK cell lectin-like receptors that includes both inhibitory and stimulatory members.
| Descriptor ID |
D055651
|
| MeSH Number(s) |
D12.776.543.750.705.895.800.200
|
| Concept/Terms |
NK Cell Lectin-Like Receptor Subfamily B- NK Cell Lectin-Like Receptor Subfamily B
- NK Cell Lectin Like Receptor Subfamily B
- Killer Cell Lectin-Like Receptor Subfamily B
- Killer Cell Lectin Like Receptor Subfamily B
NK Cell Lectin-Like Receptor Subfamily B, Member 1- NK Cell Lectin-Like Receptor Subfamily B, Member 1
- NK Cell Lectin Like Receptor Subfamily B, Member 1
- NKR-P1 Receptor
- NKR P1 Receptor
- Receptor, NKR-P1
- NKR-P1 Receptors
- NKR P1 Receptors
- Receptors, NKR-P1
- Receptors, NKR P1
- CD161 Antigen
- Antigen, CD161
- Antigens, CD161
- CD161 Antigens
|
Below are MeSH descriptors whose meaning is more general than "NK Cell Lectin-Like Receptor Subfamily B".
Below are MeSH descriptors whose meaning is more specific than "NK Cell Lectin-Like Receptor Subfamily B".
This graph shows the total number of publications written about "NK Cell Lectin-Like Receptor Subfamily B" by people in this website by year, and whether "NK Cell Lectin-Like Receptor Subfamily B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "NK Cell Lectin-Like Receptor Subfamily B" by people in Profiles.
-
CD39 and CD161 modulate Th17 responses in Crohn's disease. J Immunol. 2014 Oct 01; 193(7):3366-77.
-
The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions. Breast Cancer Res. 2011 Aug 16; 13(4):R81.
-
The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. Sci Transl Med. 2010 Oct 27; 2(55):55ra78.